Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
CR vs PNR vs XYL vs DHR vs ROP
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Medical - Diagnostics & Research
Industrial - Machinery
CR vs PNR vs XYL vs DHR vs ROP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Medical - Diagnostics & Research | Industrial - Machinery |
| Market Cap | $10.47B | $12.41B | $27.04B | $121.14B | $35.34B |
| Revenue (TTM) | $2.44B | $4.20B | $9.09B | $24.78B | $8.12B |
| Net Income (TTM) | $327M | $671M | $973M | $3.69B | $1.71B |
| Gross Margin | 41.6% | 40.9% | 38.6% | 60.7% | 69.4% |
| Operating Margin | 17.3% | 20.6% | 13.6% | 21.0% | 28.1% |
| Forward P/E | 26.7x | 14.4x | 20.6x | 20.3x | 15.7x |
| Total Debt | $1.22B | $1.64B | $1.94B | $18.42B | $9.30B |
| Cash & Equiv. | $1.73B | $102M | $1.48B | $4.62B | $297M |
CR vs PNR vs XYL vs DHR vs ROP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Crane Company (CR) | 100 | 325.4 | +225.4% |
| Pentair plc (PNR) | 100 | 196.3 | +96.3% |
| Xylem Inc. (XYL) | 100 | 171.5 | +71.5% |
| Danaher Corporation (DHR) | 100 | 115.9 | +15.9% |
| Roper Technologies,… (ROP) | 100 | 87.2 | -12.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CR vs PNR vs XYL vs DHR vs ROP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 8.2%, EPS growth 24.0%, 3Y rev CAGR 9.1%
- 261.2% 10Y total return vs XYL's 200.2%
- +7.4% vs ROP's -39.7%
- 10.1% ROA vs DHR's 4.5%, ROIC 19.9% vs 5.9%
PNR ranks third and is worth considering specifically for value.
- Lower P/E (14.4x vs 20.3x), PEG 1.10 vs 33.47
XYL is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.90, yield 1.4%
- PEG 0.90 vs DHR's 33.47
- Beta 0.90, yield 1.4%, current ratio 1.63x
- 1.4% yield, 15-year raise streak, vs ROP's 1.0%
DHR is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.89, Low D/E 35.1%, current ratio 1.87x
ROP carries the broadest edge in this set and is the clearest fit for growth and quality.
- 12.3% revenue growth vs PNR's 2.3%
- 21.1% margin vs XYL's 10.7%
- Beta 0.39 vs CR's 1.37, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs PNR's 2.3% | |
| Value | Lower P/E (14.4x vs 20.3x), PEG 1.10 vs 33.47 | |
| Quality / Margins | 21.1% margin vs XYL's 10.7% | |
| Stability / Safety | Beta 0.39 vs CR's 1.37, lower leverage | |
| Dividends | 1.4% yield, 15-year raise streak, vs ROP's 1.0% | |
| Momentum (1Y) | +7.4% vs ROP's -39.7% | |
| Efficiency (ROA) | 10.1% ROA vs DHR's 4.5%, ROIC 19.9% vs 5.9% |
CR vs PNR vs XYL vs DHR vs ROP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CR vs PNR vs XYL vs DHR vs ROP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CR leads in 2 of 6 categories
ROP leads 1 • XYL leads 1 • PNR leads 0 • DHR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 10.1x CR's $2.4B. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to XYL's 10.7%. On growth, CR holds the edge at +24.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $4.2B | $9.1B | $24.8B | $8.1B |
| EBITDAEarnings before interest/tax | $489M | $983M | $1.8B | $7.2B | $3.2B |
| Net IncomeAfter-tax profit | $327M | $671M | $973M | $3.7B | $1.7B |
| Free Cash FlowCash after capex | $262M | $716M | $966M | $5.3B | $2.6B |
| Gross MarginGross profit ÷ Revenue | +41.6% | +40.9% | +38.6% | +60.7% | +69.4% |
| Operating MarginEBIT ÷ Revenue | +17.3% | +20.6% | +13.6% | +21.0% | +28.1% |
| Net MarginNet income ÷ Revenue | +13.4% | +16.0% | +10.7% | +14.9% | +21.1% |
| FCF MarginFCF ÷ Revenue | +10.7% | +17.0% | +10.6% | +21.4% | +31.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.9% | +2.6% | +2.7% | +3.7% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -39.0% | +12.9% | +14.5% | +9.8% | +59.1% |
Valuation Metrics
Evenly matched — PNR and ROP each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 19.4x trailing earnings, PNR trades at a 43% valuation discount to DHR's 34.0x P/E. Adjusting for growth (PEG ratio), XYL offers better value at 1.27x vs DHR's 33.47x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $10.5B | $12.4B | $27.0B | $121.1B | $35.3B |
| Enterprise ValueMkt cap + debt − cash | $10.0B | $14.0B | $27.5B | $134.9B | $44.3B |
| Trailing P/EPrice ÷ TTM EPS | 28.96x | 19.40x | 29.02x | 33.96x | 24.18x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.71x | 14.35x | 20.56x | 20.29x | 15.66x |
| PEG RatioP/E ÷ EPS growth rate | 1.90x | 1.48x | 1.27x | 33.47x | 2.52x |
| EV / EBITDAEnterprise value multiple | 20.99x | 14.31x | 15.29x | 17.79x | 14.27x |
| Price / SalesMarket cap ÷ Revenue | 4.54x | 2.97x | 2.99x | 4.93x | 4.47x |
| Price / BookPrice ÷ Book value/share | 5.15x | 3.29x | 2.36x | 2.32x | 1.86x |
| Price / FCFMarket cap ÷ FCF | 30.68x | 16.64x | 29.71x | 23.03x | 14.18x |
Profitability & Efficiency
CR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PNR delivers a 17.7% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $7 for DHR. XYL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to CR's 0.59x. On the Piotroski fundamental quality scale (0–9), PNR scores 8/9 vs CR's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.3% | +17.7% | +8.5% | +7.1% | +8.8% |
| ROA (TTM)Return on assets | +10.1% | +9.9% | +5.6% | +4.5% | +5.0% |
| ROICReturn on invested capital | +19.9% | +12.1% | +7.6% | +5.9% | +6.1% |
| ROCEReturn on capital employed | +15.5% | +15.0% | +8.5% | +7.0% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.59x | 0.42x | 0.17x | 0.35x | 0.47x |
| Net DebtTotal debt minus cash | -$514M | $1.5B | $463M | $13.8B | $9.0B |
| Cash & Equiv.Liquid assets | $1.7B | $102M | $1.5B | $4.6B | $297M |
| Total DebtShort + long-term debt | $1.2B | $1.6B | $1.9B | $18.4B | $9.3B |
| Interest CoverageEBIT ÷ Interest expense | 18.68x | 11.94x | 49.32x | 18.13x | 6.50x |
Total Returns (Dividends Reinvested)
CR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CR five years ago would be worth $19,018 today (with dividends reinvested), compared to $7,681 for DHR. Over the past 12 months, CR leads with a +7.4% total return vs ROP's -39.7%. The 3-year compound annual growth rate (CAGR) favors CR at 34.9% vs ROP's -8.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.2% | -26.7% | -16.7% | -25.5% | -20.6% |
| 1-Year ReturnPast 12 months | +7.4% | -16.8% | -6.4% | -11.4% | -39.7% |
| 3-Year ReturnCumulative with dividends | +145.4% | +36.1% | +10.1% | -17.6% | -23.0% |
| 5-Year ReturnCumulative with dividends | +90.2% | +17.9% | +0.6% | -23.2% | -19.5% |
| 10-Year ReturnCumulative with dividends | +261.2% | +121.3% | +200.2% | +212.4% | +109.8% |
| CAGR (3Y)Annualised 3-year return | +34.9% | +10.8% | +3.3% | -6.3% | -8.3% |
Risk & Volatility
Evenly matched — CR and ROP each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than CR's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CR currently trades 84.6% from its 52-week high vs ROP's 58.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.37x | 1.21x | 0.90x | 0.89x | 0.39x |
| 52-Week HighHighest price in past year | $214.31 | $113.95 | $154.27 | $242.80 | $584.03 |
| 52-Week LowLowest price in past year | $159.58 | $76.69 | $113.46 | $170.74 | $313.86 |
| % of 52W HighCurrent price vs 52-week peak | +84.6% | +67.4% | +73.7% | +70.5% | +58.8% |
| RSI (14)Momentum oscillator 0–100 | 51.4 | 33.7 | 40.4 | 34.6 | 46.3 |
| Avg Volume (50D)Average daily shares traded | 481K | 1.6M | 2.1M | 4.2M | 1.2M |
Analyst Outlook
XYL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CR as "Buy", PNR as "Hold", XYL as "Hold", DHR as "Buy", ROP as "Buy". Consensus price targets imply 47.8% upside for PNR (target: $114) vs 22.8% for CR (target: $223). For income investors, XYL offers the higher dividend yield at 1.41% vs CR's 0.50%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $222.67 | $113.56 | $151.57 | $247.00 | $457.64 |
| # AnalystsCovering analysts | 28 | 41 | 40 | 42 | 23 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.3% | +1.4% | +0.7% | +1.0% |
| Dividend StreakConsecutive years of raises | 1 | 6 | 15 | 1 | 12 |
| Dividend / ShareAnnual DPS | $0.90 | $0.99 | $1.60 | $1.23 | $3.29 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.8% | +0.1% | +2.5% | +1.4% |
CR leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ROP leads in 1 (Income & Cash Flow). 2 tied.
CR vs PNR vs XYL vs DHR vs ROP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CR or PNR or XYL or DHR or ROP a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 2. 3% for Pentair plc (PNR). Pentair plc (PNR) offers the better valuation at 19. 4x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Crane Company (CR) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CR or PNR or XYL or DHR or ROP?
On trailing P/E, Pentair plc (PNR) is the cheapest at 19.
4x versus Danaher Corporation at 34. 0x. On forward P/E, Pentair plc is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Xylem Inc. wins at 0. 90x versus Danaher Corporation's 33. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CR or PNR or XYL or DHR or ROP?
Over the past 5 years, Crane Company (CR) delivered a total return of +90.
2%, compared to -23. 2% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: CR returned +261. 2% versus ROP's +109. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CR or PNR or XYL or DHR or ROP?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 39β versus Crane Company's 1. 37β — meaning CR is approximately 248% more volatile than ROP relative to the S&P 500. On balance sheet safety, Xylem Inc. (XYL) carries a lower debt/equity ratio of 17% versus 59% for Crane Company — giving it more financial flexibility in a downturn.
05Which is growing faster — CR or PNR or XYL or DHR or ROP?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 2. 3% for Pentair plc (PNR). On earnings-per-share growth, the picture is similar: Crane Company grew EPS 24. 0% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, XYL leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CR or PNR or XYL or DHR or ROP?
Roper Technologies, Inc.
(ROP) is the more profitable company, earning 19. 4% net margin versus 10. 6% for Xylem Inc. — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 13. 5% for XYL. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CR or PNR or XYL or DHR or ROP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Xylem Inc. (XYL) is the more undervalued stock at a PEG of 0. 90x versus Danaher Corporation's 33. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pentair plc (PNR) trades at 14. 4x forward P/E versus 26. 7x for Crane Company — 12. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PNR: 47. 8% to $113. 56.
08Which pays a better dividend — CR or PNR or XYL or DHR or ROP?
All stocks in this comparison pay dividends.
Xylem Inc. (XYL) offers the highest yield at 1. 4%, versus 0. 5% for Crane Company (CR).
09Is CR or PNR or XYL or DHR or ROP better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 39), 1. 0% yield, +109. 8% 10Y return). Both have compounded well over 10 years (ROP: +109. 8%, CR: +261. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CR and PNR and XYL and DHR and ROP?
These companies operate in different sectors (CR (Industrials) and PNR (Industrials) and XYL (Industrials) and DHR (Healthcare) and ROP (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
PNR, XYL, DHR, ROP pay a dividend while CR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.